202 related articles for article (PubMed ID: 33964455)
1. Very late-onset reactivation of retinopathy of prematurity post anti-VEGF bevacizumab treatment for type 1 ROP: a case report.
Taylor K; Ghergherehchi L; Rao P; Harper CA; Chang E
J AAPOS; 2021 Jun; 25(3):180-184. PubMed ID: 33964455
[TBL] [Abstract][Full Text] [Related]
2. Reactivation of retinopathy of prematurity six years after intravitreal injection of bevacizumab.
Yasin A; Sinha S; Smith R; Jain SF; Hejkal T; Rychwalski P
J AAPOS; 2023 Aug; 27(4):236-239. PubMed ID: 37451499
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage.
Nazari H; Modarres M; Parvaresh MM; Ghasemi Falavarjani K
Graefes Arch Clin Exp Ophthalmol; 2010 Dec; 248(12):1713-8. PubMed ID: 20582706
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic laser versus continued surveillance after initial bevacizumab treatment for retinopathy of prematurity.
Hong GJ; Stinnett SS; Freedman SF; Wallace DK; Prakalapakorn SG
J AAPOS; 2021 Jun; 25(3):177-180. PubMed ID: 33964453
[TBL] [Abstract][Full Text] [Related]
5. Very Late Reactivation of Retinopathy of Prematurity After Monotherapy With Intravitreal Bevacizumab.
Snyder LL; Garcia-Gonzalez JM; Shapiro MJ; Blair MP
Ophthalmic Surg Lasers Imaging Retina; 2016 Mar; 47(3):280-3. PubMed ID: 26985803
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal bevacizumab for exudative retinal detachment post laser therapy for retinopathy of prematurity.
Ehmann D; Greve M
Can J Ophthalmol; 2014 Apr; 49(2):228-31. PubMed ID: 24767234
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of intravitreal bevacizumab for zone-II retinopathy of prematurity.
Karkhaneh R; Khodabande A; Riazi-Eafahani M; Roohipoor R; Ghassemi F; Imani M; Dastjani Farahani A; Ebrahimi Adib N; Torabi H
Acta Ophthalmol; 2016 Sep; 94(6):e417-20. PubMed ID: 27009449
[TBL] [Abstract][Full Text] [Related]
8. OUTCOMES OF NONCONFLUENT DIODE LASER PANRETINAL PHOTOCOAGULATION FOR AGGRESSIVE POSTERIOR RETINOPATHY OF PREMATURITY AFTER INTRAVITREAL BEVACIZUMAB.
Mammo DA; Rubino SM; Quiram PA
Retina; 2021 Apr; 41(4):706-710. PubMed ID: 32796444
[TBL] [Abstract][Full Text] [Related]
9. A rare case of aggressive posterior retinopathy of prematurity presenting with exudative retinal detachment.
Mittal K; Chawla R; Vukkadala T; Azad SV; Vohra R; Daga J
J AAPOS; 2021 Feb; 25(1):47-50. PubMed ID: 33144201
[TBL] [Abstract][Full Text] [Related]
10. Five-Year Clinical Outcomes of Intravitreal Bevacizumab Versus Laser Photocoagulation for ROP.
Moinul P; Nanji K; Barbosa J; Sarohia GS; Fung M; Isaza G; Chaudhary V
J Pediatr Ophthalmol Strabismus; 2024; 61(1):73-74. PubMed ID: 38306241
[No Abstract] [Full Text] [Related]
11. Prospective clinical study of two different treatment regimens of combined laser photocoagulation and intravitreal bevacizumab for retinopathy of prematurity: the Indian Twin Cities ROP Study (ITCROPS) database report number 9.
Laveti V; Balakrishnan D; Rani PK; Mohamed A; Jalali S
Int Ophthalmol; 2020 Dec; 40(12):3539-3545. PubMed ID: 32776299
[TBL] [Abstract][Full Text] [Related]
12. Combined Vitrectomy and Anti-VEGF Treatment for Stage 4 Retinopathy of Prematurity With Extensive Neovascular Proliferation.
Chandra P; Kumawat D; Agarwal D; Chawla R
J Pediatr Ophthalmol Strabismus; 2020 Jan; 57(1):61-66. PubMed ID: 31972043
[TBL] [Abstract][Full Text] [Related]
13. MULTIPLE BILATERAL RETINAL BREAKS AS A LONG-TERM COMPLICATION OF RETINOPATHY OF PREMATURITY TREATED WITH INTRAVITREAL BEVACIZUMAB.
Teixeira-Pinto T; Paccola ML; Scott IU; Jorge R
Retin Cases Brief Rep; 2022 Sep; 16(5):572-575. PubMed ID: 32694276
[TBL] [Abstract][Full Text] [Related]
14. Short-term retinal detachment risk after treatment of type 1 retinopathy of prematurity with laser photocoagulation versus intravitreal bevacizumab.
Barry GP; Tauber KA; Fisher M; Greenberg S; Zobal-Ratner J; Binenbaum G
J AAPOS; 2019 Oct; 23(5):260.e1-260.e4. PubMed ID: 31513902
[TBL] [Abstract][Full Text] [Related]
15. Shaken baby syndrome in an infant treated for retinopathy of prematurity with anti-VEGF injection.
Devebacak A; Bekmez S; Eris E; Mayali H; Yurtseven I; Celik Y; Bag O
J AAPOS; 2023 Feb; 27(1):42-44. PubMed ID: 36521820
[TBL] [Abstract][Full Text] [Related]
16. Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity.
Chung EJ; Kim JH; Ahn HS; Koh HJ
Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1727-30. PubMed ID: 17690897
[TBL] [Abstract][Full Text] [Related]
17. Reactivation of retinopathy of prematurity after ranibizumab treatment.
Wong RK; Hubschman S; Tsui I
Retina; 2015 Apr; 35(4):675-80. PubMed ID: 25768252
[TBL] [Abstract][Full Text] [Related]
18. Chronic Vascular Arrest as a Predictor of Bevacizumab Treatment Failure in Retinopathy of Prematurity.
Toy BC; Schachar IH; Tan GS; Moshfeghi DM
Ophthalmology; 2016 Oct; 123(10):2166-75. PubMed ID: 27506484
[TBL] [Abstract][Full Text] [Related]
19. Buckling surgery and supplemental intravitreal bevacizumab or photocoagulation on stage 4 retinopathy of prematurity eyes.
Futamura Y; Asami T; Nonobe N; Kachi S; Ito Y; Sato Y; Hayakawa M; Terasaki H
Jpn J Ophthalmol; 2015 Nov; 59(6):378-88. PubMed ID: 26265249
[TBL] [Abstract][Full Text] [Related]
20. Slow progressive perifoveal vascular formation in an infant with aggressive posterior retinopathy of prematurity.
Chen X; Imperio R; Seely KR; Viehland C; Izatt JA; Prakalapakorn SG; Freedman SF; Toth CA
J AAPOS; 2020 Oct; 24(5):323-326. PubMed ID: 33045380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
